Labcorp's At Home Collection Kit Gets EUA Nod For Combined COVID-19 and Flu Detection


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


  • The FDA has granted Emergency Use Authorization (EUA) to Laboratory Corp of America Holdings's (NYSE:LH) combined home collection kit to detect COVID-19 and influenza A/B simultaneously in individuals as young as 2 years of age. 
  • The kit will be available at no upfront cost to those who meet clinical guidelines.
  • Starting in early October, adults 18 and over, as well as parents and guardians of children 2-17 years of age, can request the combined collection kit online through Pixel by Labcorp. 
  • The home collection kit uses the Roche Holdings AG's (OTC:RHHBY) Cobas SARS-CoV-2 & influenza A/B Test on the Cobas 6800/8800 Systems. 
  • Related content: Benzinga's Full FDA Calendar.
  • Price Action: LH stock is down 0.44% at $280.21 during the market session on the last check Friday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsHealth CareFDAGeneralBriefsCOVID-19 CoronavirusDiagnosticsHealth CareHealth Care Services